BH3-only pro-apoptotic protein (BH3-only protein)

BH3-only pro-apoptotic proteins are a specialized subgroup of the BCL-2 family that function as the primary sensors of cellular stress and initiators of the intrinsic apoptosis pathway (Youle & Strasser, 2008, Nature Reviews Molecular Cell Biology). This group includes proteins such as BIM, PUMA, BID, BAD, and NOXA, which are activated by various stimuli including DNA damage and growth factor deprivation (Shamas-Din et al., 2011, Cold Spring Harbor Perspectives in Biology). Once activated, these proteins promote cell death by either directly activating the pore-forming effectors BAX and BAK or by binding and neutralizing anti-apoptotic members like BCL-2, BCL-XL, and MCL-1 (Czabotar et al., 2014, Nature Reviews Molecular Cell Biology). In many cancers, the intrinsic apoptosis pathway is suppressed through the sequestration of BH3-only proteins by overexpressed anti-apoptotic proteins, a mechanism that promotes cell survival and chemoresistance (Montero & Letai, 2018, Cell Death & Differentiation). Therapeutic intervention focuses on BH3 mimetics, such as the FDA-approved drug venetoclax, which are small molecules designed to occupy the hydrophobic binding groove of anti-apoptotic proteins, thereby releasing BH3-only proteins to trigger mitochondrial outer membrane permeabilization and subsequent caspase-mediated cell death (Souers et al., 2013, Nature Medicine). Clinical use of these agents has revolutionized the treatment of chronic lymphocytic leukemia, though challenges remain regarding resistance mechanisms and toxicities like tumor lysis syndrome (Roberts et al., 2016, New England Journal of Medicine).

Other names

BH3-only Bcl-2 family membersPro-apoptotic BH3-only proteinsBcl-2 homology domain 3-only proteinsBH3-only proteins

BH3 mimetics bind to the hydrophobic groove of anti-apoptotic BCL-2 family proteins (e.g., BCL-2, BCL-XL, MCL-1), displacing pro-apoptotic BH3-only proteins or directly activating BAX/BAK to induce mitochondrial outer membrane permeabilization (MOMP), cytochrome c release, and caspase activation (Souers et al., 2013, Nature Medicine; Czabotar et al., 2014, Nature Reviews Molecular Cell Biology).